Abscint NV/SA
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011 (NCT06369831) | Abscint NV/SA | 2024-09-12 |
Track Abscint NV/SA automatically
Every clearance here is in the API, with alerts when new ones post.